Cellyan Biotechnology Co Ltd(HKPD) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Nov 4 at 4:00 PM ET (Korea 11/5 06:00)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | - | Insider Own | - | Shs Outstand | 0.8M | Perf Week | -15.14% |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | - | Perf Month | -10.11% |
| Enterprise Value | - | PEG | - | EPS next Q | - | Inst Own | - | Short Float | - | Perf Quarter | -77.42% |
| Income | - | P/S | - | EPS this Y | - | Inst Trans | - | Short Ratio | 0.06 | Perf Half Y | -85.77% |
| Sales | - | P/B | - | EPS next 5Y | - | ROA | - | Short Interest | 0.01M | Perf YTD | -88.78% |
| Book/sh | - | P/C | - | EPS past 3/5Y | - | ROE | - | 52W High | -93.62% ($29.00) | Perf Year | -92.29% |
| Cash/sh | - | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | 13.64% ($1.63) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | - | Gross Margin | - | Volatility(W/M) | 11.53% 13.87% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.3 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | - | EPS Q/Q | - | Profit Margin | - | RSI (14) | 34.84 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | - | Sales Q/Q | - | SMA20 | -11.68% ($2.09) | Beta | 2.51 | Target Price | - |
| Payout | - | Debt/Eq | - | Earnings | - | SMA50 | -31.15% ($2.69) | Rel Volume | 0.07 | Prev Close | $1.94 |
| Employees | 11 | LT Debt/Eq | - | EPS/Sales Surpr. | - | SMA200 | -79.76% ($9.14) | Avg Volume(3M) | 0.18M | Price | $1.85 |
| IPO | 2025/1/15 | Option/Short | No/Yes | Trades | 191 | Volume | 12,184 | Change | -4.64% |
💊 A pharmaceutical distribution company operating over-the-counter (OTC) drug distribution and e-commerce supply chain services connecting Hong Kong and mainland China. The company maintains a business structure that provides end-to-end services, including sourcing overseas OTC drugs, customs clearance, drug registration, warehousing, and logistics. As a micro-cap stock with an established revenue base, it tends to react sensitively to growth in the cross-border pharmaceutical market and changes in the regulatory environment.
Over the past 1 year, on the lower side
94% below its 1-year high.
Traded less than usual. That is 7% of its average volume.
Holding long would have lost money
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership is about average
Shareholder Composition Guide
Tap to view numbers
It ranks #11 of 11 in the industry
Based on market cap of $5M.
COSM#7 Cosmos Health Inc $33M PER - 
ACH#8 Accendra Health Inc $21M PER - 
YI#9 111 Inc ADR $16M PER - 
MEDS#10 DataMEDS AI Inc $7M PER - HKPD#11 Cellyan Biotechnology Co Ltd $5M PER - 
FAQ
What kind of company is HKPD?
HKPD belongs to the Healthcare sector and operates in the Medical Distribution industry.
What is the market cap of HKPD?
The market cap of HKPD is approximately $5M, ranking 5,640 within its sector.
What is the 52-week high and low for HKPD?
HKPD has recorded a 52-week high of $29.00 and a low of $1.63.
